Making a patient impact, one person at a time
We focus on solutions that are creative, scalable, and, above all – practical. The Max Foundation and our partners want to support people living with cancer and help create real, positive changes in their lives.
The following data is from our 2025 Monitoring and Evaluation Report.
Partnerships
Patients
Operations
Partnerships
933
total partners, including corporate partners and supporters, ministries of health, NGOs, and affiliated organizations
483
partner healthcare professionals
377
partner medical institutions
Patients
40,561
patients provided access to treatment each year
11,475
diagnostic tests provided to patients each year
23,504
patients receiving support services, including education and transportation assistance
Operations
84
countries where medication access and support services are provided
15
diseases we provide medication access for
103
Max employees spanning 24 countries
Patient Stories
Our core belief is that all people facing illness deserve access to immediate and effective medications and treatment, no matter where they live. Hear from patients about the impact of cancer on their lives, families, and communities.
Dipak, musician from Nepal
“Today, every song I play reminds me of how far I have come. It reminds me of every doctor, every healthcare worker, every member of the Max team in Nepal, and every person who believed in me when I struggled to believe in myself. Medication didn’t just change my treatment, it changed my life.”
Read More
Elizabeth, nurse and mother from Kenya
“My ultimate motivation to fight—and to live—is my family. Above all else, my heart longs to see my children grow up with both of their parents by their side, reaching every dream and landmark I have always envisioned for them.”
Read More Where we work
From the mountains of Nepal to the coast of Mozambique, we’re bridging inequities for people facing cancer around the world. Max and its partners currently operate in more than 80 low- and middle-income countries.
In 2025, we provided 17 treatments for 15 diseases in the following regions:
- Africa and the Middle East – 13,659 patients accessed treatment
- Asia – 3,773 patients accessed treatment
- Eastern Europe – 5,882 patients accessed treatment
- Latin America – 4,151 patients accessed treatment
- South Asia – 10,822 patients accessed treatment
2025 Annual Report
With nearly 5,000 new patients enrolled in 2025 – and for the first time surpassing 40,000 patients treated in a single year – we are firmly on track to meet our goals.